Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major

Luca Antonio Felice Di Odoardo1, Marianna Giuditta2,3, Elena Cassinerio3

  • 1Cardiovascular Disease Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, via F. Sforza 35, 20122, Milan, Italy. lucadiod@inwind.it.

Insights

Strain imaging detects subclinical myocardial dysfunction in thalassemia major patients, even without significant iron overload. This method aids in timing cardioactive treatments for iron cardiomyopathy.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Hematology

Background:

  • Traditional echocardiography fails to detect early iron overload cardiomyopathy and myocardial iron deposition.
  • Thalassemia major (TM) patients are at risk for cardiac complications due to iron overload.

Purpose of the Study:

  • To determine myocardial systolic strain indices in TM patients.
  • To assess the relationship between strain indices and cardiac magnetic resonance (CMR) T2* values, an indicator of myocardial iron overload severity.

Main Methods:

  • Speckle tracking analysis was used to assess regional myocardial strains and rotation in 55 TM patients and 20 controls.
  • TM patients were categorized into groups based on CMR-T2* values (low T2* ≤20 ms for significant iron overload, normal T2* >20 ms).

Main Results:

  • TM patients exhibited significantly decreased circumferential and radial strain and reduced end-systolic rotation compared to controls.
  • No significant differences in strain or rotation were found between TM groups with low and normal T2* values.
  • No significant correlation was observed between myocardial strain, rotation, and CMR-T2* values.

Conclusions:

  • Myocardial iron overload is not the sole cause of iron cardiomyopathy in TM.
  • Strain imaging can identify subclinical myocardial dysfunction in TM patients, independent of CMR-T2* values.
  • Strain imaging may assist in optimizing the timing of cardioactive treatments for TM patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
680
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
666
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
369